• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狼疮抗凝物与脾脏原发性恶性淋巴浆细胞淋巴瘤相关:4例报告

Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: a report of four patients.

作者信息

Ciaudo M, Horellou M H, Audouin J, De Carbonnieres C, Conard J, Samama M

机构信息

Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris, France.

出版信息

Am J Hematol. 1991 Dec;38(4):271-6. doi: 10.1002/ajh.2830380404.

DOI:10.1002/ajh.2830380404
PMID:1746535
Abstract

Primary lymphoma of the spleen is characterized by predominant splenomegaly. Lymphoplasmacytic malignant lymphoma of the spleen, of low malignancy in the Kiel classification, low and intermediate grade in the National Cancer Institute Working Formulation (NCIWF), is rare. It is often associated with a monoclonal immunoglobulin M (IgM). Four patients presenting with primary splenic lymphoma of plasmacytic type associated with a high level of monoclonal IgM and a lupus anticoagulant (LA) are described. This association has not previously been reported. In contrast with the usual heterogeneity of LA, this LA is relatively homogeneous with an important prolongation of the prothrombin time (greater than 18 sec for a control of 12), more prolonged partial thromboplastin time (PTT) of the mixture patient + control plasma than PTT of the patient plasma. Despite the important coagulation abnormalities, none of these four patients has presented any hemorrhagic or thrombotic complications, even during major surgery such as splenectomy. The lupus-like anticoagulant effect ran parallel with the monoclonal IgM. Survival, after splenectomy and chemotherapy, appears to be favourable: three patients are alive with survivals of greater than or equal to 7 years. The follow-up is as yet too short for the last patient.

摘要

脾脏原发性淋巴瘤的特征是脾脏明显肿大。脾脏的淋巴浆细胞性恶性淋巴瘤,在基尔分类中恶性程度低,在美国国立癌症研究所工作分类(NCIWF)中为低级别和中级别,较为罕见。它常与单克隆免疫球蛋白M(IgM)相关。本文描述了4例表现为浆细胞型原发性脾淋巴瘤且伴有高水平单克隆IgM和狼疮抗凝物(LA)的患者。这种关联此前尚未见报道。与通常LA的异质性不同,该LA相对均一,凝血酶原时间显著延长(对照为12秒时大于18秒),患者血浆与对照血浆混合后的部分凝血活酶时间(PTT)比患者血浆的PTT延长更多。尽管存在严重的凝血异常,但这4例患者均未出现任何出血或血栓形成并发症,即使在脾切除术等大手术期间也是如此。狼疮样抗凝作用与单克隆IgM平行。脾切除术后化疗的生存情况似乎良好:3例患者存活,生存期大于或等于7年。最后1例患者的随访时间至今仍较短。

相似文献

1
Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: a report of four patients.狼疮抗凝物与脾脏原发性恶性淋巴浆细胞淋巴瘤相关:4例报告
Am J Hematol. 1991 Dec;38(4):271-6. doi: 10.1002/ajh.2830380404.
2
Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.活化部分凝血活酶时间延长患者中狼疮抗凝物与抗心磷脂抗体的相关性
Am J Med. 1990 Feb;88(2):112-6. doi: 10.1016/0002-9343(90)90458-p.
3
IgM anticoagulant with acquired abnormalities in factor VIII.伴有获得性凝血因子VIII异常的IgM抗凝剂
Thromb Res. 1982 Sep 15;27(6):703-12. doi: 10.1016/0049-3848(82)90008-1.
4
Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma: a case report.狼疮抗凝物对脾边缘区淋巴瘤中血管性血友病因子检测的干扰:一例报告
Blood Coagul Fibrinolysis. 2015 Jun;26(4):454-7. doi: 10.1097/MBC.0000000000000240.
5
Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.脾边缘区淋巴瘤中的狼疮抗凝物与血栓形成
Thromb Res. 2014 Nov;134(5):980-4. doi: 10.1016/j.thromres.2014.08.021. Epub 2014 Aug 29.
6
Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.在确定狼疮患者的血栓形成亚组方面,凝血筛查比抗心磷脂抗体酶联免疫吸附测定更具特异性。
Ann Rheum Dis. 1988 May;47(5):364-71. doi: 10.1136/ard.47.5.364.
7
Prolonged Activated Partial Thromboplastin Time and False-Positive Results for Fibrinogen and Fibrin Degradation Products in a B-Cell Lymphoma Patient.
Ann Clin Lab Sci. 2018 May;48(3):377-380.
8
Lupus anticoagulant in the acquired immunodeficiency syndrome.获得性免疫缺陷综合征中的狼疮抗凝物
JAMA. 1986 Jul 25;256(4):491-3.
9
The laboratory heterogeneity of lupus anticoagulants.狼疮抗凝物的实验室异质性。
Arch Pathol Lab Med. 1985 Oct;109(10):946-51.
10
[Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities].[狼疮抗凝物在系统性红斑狼疮及其他临床病症中的存在情况]
Invest Clin. 1990;31(1):45-55.

引用本文的文献

1
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association.狼疮抗凝物与低度B细胞淋巴瘤及IgM副蛋白血症相关,在稀释蝰蛇毒时间(DRVVT)和硅化凝血时间(SCT)检测中出现狼疮辅助因子现象——一种可能的新型关联。
Thromb J. 2024 Dec 5;22(1):109. doi: 10.1186/s12959-024-00680-x.
2
Prevalence and Resolution of Lupus Anticoagulant in Children.儿童狼疮抗凝物的患病率及转归
Ochsner J. 2016 Summer;16(2):172-5.
3
Multiple autoantibody production in a patient with splenic lymphoma.
Ann Hematol. 1994 May;68(5):251-4. doi: 10.1007/BF01737426.
4
Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.恶性肿瘤抗心磷脂抗体阳性患者血栓栓塞发生率增加。
Br J Cancer. 1995 Aug;72(2):447-51. doi: 10.1038/bjc.1995.353.